Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

NCT04417465

Conditions
Advanced Solid Tumors Cancer, Carcinoma, Carcinoma, Squamous Cell, +6 more
Locations
  • Highlands Oncology Group Springdale Springdale, Arkansas, United States
  • Yale University New Haven, Connecticut, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
View all 17 locations
View Trial Details
Completed

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

NCT05104567

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +29 more
Locations
  • City of Hope Site Number : 8400007 Duarte, California, United States
  • AdventHealth Orlando Site Number : 8400005 Orlando, Florida, United States
  • Seattle Cancer Care Alliance Site Number : 8400009 Seattle, Washington, United States
  • Investigational Site Number : 0560002 Brussels, Belgium
View all 29 locations
View Trial Details
Completed

A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)

NCT05459129

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • City of Hope Duarte, California, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View Trial Details
Completed

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

NCT04344795

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +41 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Baystate Gynecologic Oncology Springfield, Massachusetts, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

NCT04879849

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
Locations
  • Cedars Sinai Medical Center Duarte, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Laura And Isaac Perlmutter Cancer Center New York, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View Trial Details
Completed

A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

NCT05323656

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Siteman Cancer Center - St. Peters City of Saint Peters, Missouri, United States
  • Siteman Cancer Center - West County Creve Coeur, Missouri, United States
  • Siteman Cancer Center - North County Florissant, Missouri, United States
View all 24 locations
View Trial Details

Related conditions